Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma

MLA

Magarotto, V., et al. Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3062..7ae8e80ead90333b24487f9be7eb9955&authtype=sso&custid=ns315887.

APA

Magarotto, V., Sonneveld, P., Voorhees, P., Paba-Prada, C., Plesner, T., Mellqvist, U. H., Byrne, C., Harmenberg, J., Nordstrom, E., Palumbo, A., & Richardson, P. (2015). Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma.

Chicago

Magarotto, V., P. Sonneveld, P. Voorhees, C. Paba-Prada, T. Plesner, U. H. Mellqvist, C. Byrne, et al. 2015. “Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3062..7ae8e80ead90333b24487f9be7eb9955&authtype=sso&custid=ns315887.